|Bid||13.40 x 900|
|Ask||14.06 x 2900|
|Day's Range||13.68 - 13.88|
|52 Week Range||11.72 - 14.74|
|Beta (5Y Monthly)||0.63|
|PE Ratio (TTM)||7.53|
|Forward Dividend & Yield||0.78 (5.61%)|
|Ex-Dividend Date||Nov 12, 2021|
|1y Target Est||N/A|
Subscribe to Yahoo Finance Plus to view Fair Value for BGTLearn more
LogicBio Therapeutics, Inc. (Nasdaq:LOGC), a clinical-stage genetic medicine company pioneering gene delivery and gene editing platforms to address rare and serious diseases from infancy through adulthood, today announced that chief executive officer Frederic Chereau will be presenting an overview of the company at upcoming investor conferences.
Today, BlackRock Enhanced Government Fund, Inc. (NYSE: EGF) , BlackRock Debt Strategies Fund, Inc. (NYSE: DSU), BlackRock Floating Rate Income Strategies Fund, Inc. (NYSE: FRA), BlackRock Floating Rate Income Trust (NYSE: BGT), BlackRock Corporate High Yield Fund, Inc. (NYSE: HYT), BlackRock Credit Allocation Income Trust (NYSE: BTZ), BlackRock Limited Duration Income Trust (NYSE: BLW), BlackRock Core Bond Trust (NYSE: BHK), and BlackRock Multi-Sector Income Trust (NYSE: BIT) (collectively, the "Funds") paid the following distributions per share:
Certain BlackRock closed-end funds (the "Funds") announced distributions today as detailed below.